Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Höper, Marius [VerfasserIn]   i
 Pan, Zixuan [VerfasserIn]   i
 Eichstaedt, Christina [VerfasserIn]   i
 Benjamin, Nicola [VerfasserIn]   i
 Grünig, Ekkehard [VerfasserIn]   i
Titel:Mortality in pulmonary arterial hypertension
Titelzusatz:prediction by the 2015 European pulmonary hypertension guidelines risk stratification model
Verf.angabe:Marius M. Hoeper, Tilmann Kramer, Zixuan Pan, Christina A. Eichstaedt, Jens Spiesshoefer, Nicola Benjamin, Karen M. Olsson, Katrin Meyer, Carmine Dario Vizza, Anton Vonk-Noordegraaf, Oliver Distler, Christian Opitz, J. Simon R. Gibbs, Marion Delcroix, H. Ardeschir Ghofrani, Doerte Huscher, David Pittrow, Stephan Rosenkranz, Ekkehard Grünig
E-Jahr:2017
Jahr:August 3, 2017
Umfang:10 S.
Fussnoten:Gesehen am 09.05.2018
Titel Quelle:Enthalten in: European respiratory journal
Ort Quelle:Lausanne : ERS, 1988
Jahr Quelle:2017
Band/Heft Quelle:50(2017,2) Artikel-Nummer 1700740, 10 Seiten
ISSN Quelle:1399-3003
Abstract:The 2015 European pulmonary hypertension (PH) guidelines propose a risk stratification strategy for patients with pulmonary arterial hypertension (PAH). Low-, intermediate- and high-risk strata are defined by estimated 1-year mortality risks of <5%, 5-10% and >10%, respectively. This risk assessment strategy awaits validation. We analysed data from patients with newly diagnosed PAH enrolled into COMPERA (Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension), a European-based PH registry. An abbreviated version of the risk assessment strategy proposed by the European PH guidelines was applied, using the following variables: World Health Organization functional class, 6-min walking distance, brain natriuretic peptide or its N-terminal fragment, right atrial pressure, cardiac index and mixed venous oxygen saturation. Data from 1588 patients were analysed. Mortality rates were significantly different between the three risk strata (p<0.001 for all comparisons). In the entire patient population, the observed mortality rates 1 year after diagnosis were 2.8% in the low-risk cohort (n=196), 9.9% in the intermediate-risk cohort (n=1116) and 21.2% in the high-risk cohort (n=276). In addition, the risk assessment strategy proved valid at follow-up and in major PAH subgroups. An abbreviated version of the risk assessment strategy proposed by the current European PH guidelines provides accurate mortality estimates in patients with PAH. Tweetable abstract @ERSpublications click to tweetThe risk stratification strategy proposed by the current European PH guidelines allows accurate survival prediction http://ow.ly/KsWk30c46nK
DOI:doi:10.1183/13993003.00740-2017
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

Volltext ; Verlag: http://dx.doi.org/10.1183/13993003.00740-2017
 Volltext: http://erj.ersjournals.com/content/50/2/1700740
 DOI: https://doi.org/10.1183/13993003.00740-2017
Datenträger:Online-Ressource
Sprache:eng
K10plus-PPN:1574285394
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/68251035   QR-Code
zum Seitenanfang